Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
19 | 10277786 | intron variant | G/A | snv | 2.1E-03 |
|
0.700 | 1.000 | 2 | 2012 | 2012 | ||||||||||
|
19 | 10277786 | intron variant | G/A | snv | 2.1E-03 |
|
0.700 | 1.000 | 2 | 2012 | 2012 | ||||||||||
|
19 | 10284797 | missense variant | G/A | snv |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||||||
|
19 | 10281703 | intron variant | -/C | delins | 7.6E-04 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.851 | 0.280 | 19 | 10279982 | intron variant | C/G | snv | 0.52 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.851 | 0.280 | 19 | 10279982 | intron variant | C/G | snv | 0.52 |
|
0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.280 | 19 | 10279982 | intron variant | C/G | snv | 0.52 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.851 | 0.280 | 19 | 10279982 | intron variant | C/G | snv | 0.52 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.851 | 0.280 | 19 | 10279982 | intron variant | C/G | snv | 0.52 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.280 | 19 | 10279982 | intron variant | C/G | snv | 0.52 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.851 | 0.280 | 19 | 10279982 | intron variant | C/G | snv | 0.52 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.280 | 19 | 10279982 | intron variant | C/G | snv | 0.52 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.851 | 0.280 | 19 | 10279982 | intron variant | C/G | snv | 0.52 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.280 | 19 | 10279982 | intron variant | C/G | snv | 0.52 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.851 | 0.280 | 19 | 10279982 | intron variant | C/G | snv | 0.52 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.280 | 19 | 10279982 | intron variant | C/G | snv | 0.52 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.120 | 19 | 10286727 | non coding transcript exon variant | C/T | snv | 0.34 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.120 | 19 | 10286727 | non coding transcript exon variant | C/T | snv | 0.34 |
|
0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.120 | 19 | 10286727 | non coding transcript exon variant | C/T | snv | 0.34 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.120 | 19 | 10286727 | non coding transcript exon variant | C/T | snv | 0.34 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.120 | 19 | 10286727 | non coding transcript exon variant | C/T | snv | 0.34 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.120 | 19 | 10286727 | non coding transcript exon variant | C/T | snv | 0.34 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
19 | 10269461 | intron variant | G/A | snv | 3.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
19 | 10269461 | intron variant | G/A | snv | 3.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
19 | 10269461 | intron variant | G/A | snv | 3.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 |